Autoimmune liver disease - are there spectra that we do not know?

Comparative Hepatology

Volumn 10, Issue , 2011, Pages

  Fallatah, Hind I ^a   Akbar, Hisham O ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Autoimmune cholangiti; Autoimmune hepatitis; Autoimmune liver disease; Hepatocellular; Primary biliary cirrhosis; Primary sclerosing cholangitis; Scholestasis; Ursodeoxycholic acid

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; ASCITES; AUTOIMMUNE DISEASE; BILE DUCT INJURY; CASE REPORT; CHOLESTASIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; MALE; MELENA; PERIPHERAL EDEMA; PRURITUS; RECTUM HEMORRHAGE; STEATOSIS;

EID: 80052584948     PISSN: None     EISSN: 14765926     Source Type: Journal    
DOI: 10.1186/1476-5926-10-9     Document Type: Article

References (47)

1. Kumagi T, Alswat K, Hirschfield GM, Heathcote J. New insights into autoimmune liver diseases. Hepatol Res 2008, 38:745-761. 10.1111/j.1872-034X.2008.00366.x, 18462376.
2. Hirschfield GM, Al-Harthi N, Heathcote EJ. Review Current Status of Therapy in Autoimmune Liver Disease. Ther Adv Gastroenterol 2009, 2:11-28.
3. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009, 51:237-267. 10.1016/j.jhep.2009.04.009, 19501929, European Association for the Study of the Liver.
4. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001, 33:994-1002. 10.1053/jhep.2001.23316, 11283866.
5. Mackay IR. Autoimmune diseases of the liver autoimmune hepatitis and primary biliary cirrhosis: Unfinished business. Hepatol Res 2007, 37:S357-364. 10.1111/j.1872-034X.2007.00230.x, 17931187.
6. Freese D. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002, 36:479-497. 10.1053/jhep.2002.34944, 12143059.
7. Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M. Type I autoimmune hepatitis clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 2006, 24:1051-1057. 10.1111/j.1365-2036.2006.03104.x, 16984499.
8. Bellomo-Brandão MA, Costa-Pinto EA, De Tommaso AM, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq Gastroenterol 2006, 43:45-49. 10.1590/S0004-28032006000100012, 16699618.
9. Fallatah H, Akbar H, Qari A. Autoimmune hepatitis single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia. Saudi J Gastroenterol 2010, 16:95-99. 10.4103/1319-3767.61235, 3016513, 20339178.
10. Huang H, Huang Y, Wu J, Tsay S, Huo T, Wang YJ, Lo JC, Chen CY, Li CP, Chang FY, Lee SD. Characteristics of autoimmune hepatitis in Taiwan the 11 years experiences of a medical center. Chinese Medical Journal 2002, 65:563-569.
11. Tang CP, Shiau YT, Huang YH, Tsay SH, Huo TI, Wu JC, Lin HC, Lee SD. Cholestatic jaundice as the predominant presentation in a patient with Autoimmune Hepatitis. J Chin Med Assoc 2008, 71:45-48. 10.1016/S1726-4901(08)70072-8, 18218560.
12. Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 2004, 24:322-329. 10.1111/j.1478-3231.2004.0924.x, 15287855.
13. Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja A, Desmet V, Eddleston AL, Gerber MA, Hoofnagle JH, Kakumu MacSween RN, Maddrey W, Manns MP, Büschenfelde KH, Mieli-Vergani G, Portmann Reed BW, Schalm SW, Scheuer P, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M. Meeting Report International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005. 10.1002/hep.1840180435, 8406375.
14. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group report review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938. 10.1016/S0168-8278(99)80297-9, 10580593.
15. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW, . International Autoimmune Hepatitis Group Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176. 10.1002/hep.22322, 18537184, International Autoimmune Hepatitis Group.
16. Czaja A. Current and future treatments of Autoimmune Hepatitis. Expert Rev Gastroenterol Hepatol 2009, 3:269-291. 10.1586/egh.09.15, 19485809.
17. Teufel A, Galle P, Kanzler S. Update on autoimmune hepatitis. WJG 2009, 15:1035-1041. 10.3748/wjg.15.1035, 2655176, 19266594.
18. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary Biliary Cirrhosis. Hepatology 2009, 50:291-308. 10.1002/hep.22906, 19554543.
19. Moreira RK, Revetta F, Koehler E, Washington MK. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol 2010, 16:453-457. 10.3748/wjg.v16.i4.453, 2811797, 20101770.
20. Rautiainen H, Karkkainen P, Karvonen AL, Nurmi H, Pikkarainen P, Nuutinen H, Färkkilä M. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis a three year randomized trial. Hepatology 2005, 41:747-752. 10.1002/hep.20646, 15754377.
21. Sánchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis atypical primary biliary cirrhosis or autoimmune cholangitis. J Clin Gastroenterol 1996, 23:191-8. 10.1097/00004836-199610000-00007, 8899500.
22. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR. Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 1999, 19:122-128. 10.1111/j.1478-3231.1999.tb00021.x, 10220742.
23. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 2000, 31:1231-1238. 10.1053/jhep.2000.7878, 10827147.
24. Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, Granito A, Cassani F, Loria P, Lenzi M, Bianchi FB. True antimitochondrial antibody-negative primary biliary cirrhosis low sensitivity of the routine assays or both. Clin Exp Immunol 2004, 135:154-158. 10.1111/j.1365-2249.2004.02332.x, 1808914, 14678277.
25. Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis a subset of primary biliary cirrhosis. Liver Int 2008, 28:233-239. 10.1111/j.1478-3231.2007.01651.x, 18251980.
26. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ, . American Association for the Study of Liver Diseases Diagnosis and management of primary Sclerosing Cholangitis. Hepatology 2010, 51:660-678. American Association for the Study of Liver Diseases.
27. Bjornsson E, Olsson R, Bergquist A, Lindgren S, Braden B, Chapman RW, Boberg KM, Angulo P. The natural history of small-sclerosing cholangitis. Gastroenterology 2008, 134:975-980. 10.1053/j.gastro.2008.01.042, 18395078.
28. Lindor KD, . Ursodiol for primary sclerosing cholangitis Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Group. N Engl J Med 1997, 336:691-695. 10.1056/NEJM199703063361003, 9041099, Ursodiol for primary sclerosing cholangitis.
29. Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R. Primary sclerosing cholangitis a 5-year multicenter randomized controlled study. Gastroenterology 2005, 129:1464-1472. 10.1053/j.gastro.2005.08.017, 16285948.
30. Heurgué A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, Picot R, Louvet H, Frémond L, Geoffroy P, Schmit JL, Cadiot G, Thiéfin G. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 2007, 31:17-25. 10.1016/S0399-8320(07)89323-7, 17273128.
31. Schramm C, Lohse AW. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis. Clin Rev Allergy Immunol 2005, 28:105-114. 10.1385/CRIAI:28:2:105, 15879617.
32. Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008, 14:3368-3373. 10.3748/wjg.14.3368, 2716591, 18528934.
33. Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. Overlap of primary biliary cirrhosis and autoimmune hepatitis Characteristics therapy and long term outcomes. J Gastroenterol Hepatol 2010, 25:376-82. 10.1111/j.1440-1746.2009.06018.x, 19817953.
34. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome clinical features and response to therapy. Hepatology 1998, 28:296-301. 10.1002/hep.510280203, 9695990.
35. Neuhauser M, Bjornsson E, Treeprasertsuk S. Autoimmune hepatitis-PBC overlap syndrome a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010, 105:345-53. 10.1038/ajg.2009.616, 19888204.
36. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood a 16-year prospective study. Hepatology 2001, 33:544-553. 10.1053/jhep.2001.22131, 11230733.
37. Silveira MG, Lindor KD. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases. Expert Rev Gastroenterol Hepatol 2007, 1:329-40. 10.1586/17474124.1.2.329, 19072425.
38. Silveira MG, Talwalkar JA, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis long-term outcomes. Am J Gastroenterol 2007, 102:1244-1250. 10.1111/j.1572-0241.2007.01136.x, 17319931.
39. Kaneko A, Kubo M, Yamada R, Tanimura T, Yamaguchi D, Yamamoto M, Tatsumi N, Nakama A, Mita E, Kato M, Hijioka T, Oshita M, Ito T, Imanaka K, Katayama K, Sato M, Yoshihara H, Kiriyama K, Imai Y, Kashihara T, Fukui H, Suzuki K, Miyoshi S, Yamada A, Yakushijin T, Mochizuki K, Hiramatsu N, Takehara T, Hayashi N. Investigation of simplified international diagnostic criteria for autoimmune hepatitis. Nippon Shokakibyo Gakkai Zasshi 2010, 107:732-742.
40. Krok KL, Munoz SJ. Management of autoimmune and cholestatic liver disorders. Clin Liver Dis 2009, 13:295-316. 10.1016/j.cld.2009.02.011, 19442920.
41. Ghonaim M, Al-Ghamdi A, El-Bana H, Bakr A, Ghoneim E, El-Edel R, Hassona M, Shoeib S, Allam H. Autoantibodies in chronic liver disease. Egypt J Immunol 2005, 12:101-111.
42. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997, 44:417-425.
43. Triantafyllou K, Vlachogiannakos J, Ladas SD. Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol 2010, 24:203-215. 10.1016/j.bpg.2010.02.004, 20227033.
44. Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Clinical course and outcomes of drug-induced liver injury nimesulide as the first implicated medication. Dig Liver Dis 2010, 42:143-148. 10.1016/j.dld.2009.06.009, 19625223.
45. Raja K, Thung SN, Fiel MI, Chang C. Drug-induced steatohepatitis leading to cirrhosis long-term toxicity of amiodarone use. Semin Liver Dis 2009, 29:423-428. 10.1055/s-0029-1240011, 19826976.
46. Malatjalian DA, Ross JB, Williams CN, Colwell SJ, Eastwood BJ. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia with analysis of risks from obesity diabetes and alcohol consumption during long term follow-up. Can J Gastroenterol 1996, 10:369-375.
47. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010, 28:155-161. 10.1159/000282080, 20460905.